Achievement of Cardiometabolic Goals in Aware Hypertensive Patients in Spain

Egan, Brent M.

doi:10.1161/hypertensionaha.112.198994

Cited by 5 publications

(5 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, in our experience, hypertension control was double when evaluated with ABPM, thus conveying the message to practising physicians that they are doing better in BP control than is believed on the basis of office-or population-based surveys [17], especially in Europe where rates of hypertension control continue to be lower than that in the United States [34]. Nevertheless, the area corresponding to uncontrolled hypertension constituted the wider one when looking whole samples of hypertensives ( figure 1).…”

Section: The Burden Of Uncontrolled Hypertensionmentioning

confidence: 76%

“…Due to the white‐coat effect, ABPM‐based hypertension control offer a much better figure (about 51%) than that assessed at the office (about 24%). Therefore, in our experience, hypertension control was double when evaluated with ABPM, thus conveying the message to practising physicians that they are doing better in BP control than is believed on the basis of office‐ or population‐based surveys , especially in Europe where rates of hypertension control continue to be lower than that in the United States .…”

Section: The Burden Of Uncontrolled Hypertensionmentioning

confidence: 81%

See 1 more Smart Citation

Ambulatory blood pressure monitoring in daily clinical practice – the Spanish ABPM Registry experience

Gorostidi

Banegas

Sierra

et al. 2015

Eur J Clin Investigation

View full text Add to dashboard Cite

Many patients are hypertensive at the medical settings but show normal blood pressure out of the doctor's office, and are classified as white-coat hypertensives. On the other hand, many patients with controlled hypertension at the clinic show ambulatory blood pressure levels above the thresholds considered for an adequate blood pressure control, known as having masked hypertension. Using data from the Spanish Ambulatory Blood Pressure Monitoring Registry (Spanish ABPM Registry), a national program developed to promote the use of the ambulatory technique for hypertension management in daily practice, we have reviewed the main strengths of this approach, that is the ability to detect discrepancies of blood pressure status with respect to office blood pressure measurement, and to better assess accurate rates of hypertension control. White-coat hypertension within patients with elevated office blood pressure, and masked hypertension within office-controlled patients affected one of three patients in each office status. On the other hand, rates of ambulatory blood pressure control (50%) doubled those of office blood pressure control (25%), still remaining half the patients uncontrolled. We think that a systematic use of ambulatory blood pressure monitoring, and strategies to improve blood pressure control constitute key priorities in hypertension management. Keywords Ambulatory blood pressure measurement, blood pressure, blood pressure measurement, hypertension, masked hypertension, white-coat hypertension. Eur J Clin Invest 2016; 46 (1): 92-98

show abstract

Section: The Burden Of Uncontrolled Hypertensionmentioning

confidence: 76%

Section: The Burden Of Uncontrolled Hypertensionmentioning

confidence: 81%

Ambulatory blood pressure monitoring in daily clinical practice – the Spanish ABPM Registry experience

Gorostidi

Banegas

Sierra

et al. 2015

Eur J Clin Investigation

View full text Add to dashboard Cite

show abstract

“…However, health services also need to improve because 5 of every 10 persons with total cholesterol >240 mg/dL are not being treated. Also, 1 of every 4 subjects has BP >140/90 mm Hg, about half of whom are unaware of their hypertension, highlighting the improved but still high hypertension unawareness in Spain, [25][26][27] which is comparable with other European countries, 28,29 but it is much higher than in the United States 30 In recent years, several prevention campaigns have been conducted in Spain to increase physical activity, improve diet, and reduce smoking habit. But the results does not seem to reflect the effort.…”

Section: Discussionmentioning

confidence: 97%

Cardiovascular Health in a Southern Mediterranean European Country

Graciani

León‐Muñoz

Guallar‐Castillón

et al. 2013

Circ: Cardiovascular Quality and Outcomes

View full text Add to dashboard Cite

Background-There are no published data on cardiovascular health from a national representative sample in a European country. Methods and Results-Data were taken from a crosssectional study among 11 408 persons representative of the Spanish population ≥18 years of age during 2008 to 2010. Information was collected at participants' homes through structured questionnaires, physical examination, and fasting blood samples, which were centrally analyzed. The American Heart Association has defined ideal cardiovascular health as the simultaneous presence of 4 health behaviors (nonsmoking, body mass index <25 kg/m 2 , physical activity at goal, and diet consistent with current recommendations) and 4 health factors (nonsmoking, untreated total cholesterol <200 mg/dL, untreated blood pressure <120/80 mm Hg, and untreated fasting glucose <100 mg/dL) in the absence of clinical cardiovascular disease and diabetes mellitus. Only 0.2% of subjects attained ideal values for all 7 cardiovascular disease health metrics and 3.4% and 15.3% for at least 6 and 5 metrics, respectively. The percentage of subjects who achieved the 4 ideal lifestyles was lower than that for the 4 ideal health factors (0.7% versus 8.1%). Lack of ideal diet was the most frequent health metrics (88.9%). In general, ideal levels of cardiovascular disease health metrics were more frequent in younger subjects, women, and those with higher education. Conclusion-Cardiovascular

show abstract

“…over the past 10 years, the control of Cv risk factors has improved especially at the older age strata, 3 but most of this success does not seem to be related to a reduced impact of hypertension. 4,5 As recently pointed out, 6,7 the reduction of hypertensionassociated Cv morbidity and mortality is almost exclusively a consequence of the results of randomized controlled trials (rCts), especially those comparing active medications versus placebo. 8 Unfortunately, despite this success, arterial hypertension remains the leading Cv risk factor, to which 13% of global death is attributable.…”

mentioning

confidence: 99%